¡Ya estamos en !
Descubre más
Evoke Pharma
Excluida de cotización
EVOK dejó de cotizar en bolsa el 16 de diciembre de 2025.
Acerca de: Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Empleados: 3
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
0%
Neutral
0%
Negativo
0%
Gráficos de precios implementados con Lightweight Charts™